Back to News
Market Impact: 0.05
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Source: GlobeNewswire
The article only announces a conference call scheduled for September 15, 2026, at 8:30 a.m. ET. It provides no financial results, guidance, corporate developments, or market-moving details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- Budget 2026 speech
- Fortinet’s stock is taking a dive after earnings. Here’s why.
- Wendy's shares jump 15% as Nelson Peltz's Trian offers $1.4 billion to buy burger chain
- The UK cuts energy bills, taxes banks and boosts defense in high-stakes budget